Observational studyScience progress
Assessing diaphragm dysfunction in ICU patients with COVID-19 pneumonia: A prospective observational cohort study.
Observational study in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveUltrasonography has been commonly employed during the Coronavirus Disease 2019 (COVID-19) pandemic to assess lung and heart conditions; however, diaphragm ultrasonography (DU) has not been as widely acknowledged. This study aimed to assess the prevalence of diaphragm dysfunction (DD) in non-intubated critically ill patients with COVID-19 pneumonia on intensive care unit (ICU) admission and to examine the correlation between DD and various prognostic factors during their ICU stay.MethodsThis prospective observational cohort study included 79 consecutive patients admitted to the intensive care unit (ICU) over an eight-month period. DU was performed within 24 h of admission by the same ultrasonographer. Diaphragm excursion was measured, and the diaphragmatic thickening fraction (DTF) was calculated.ResultsA total of 79 patients were included in the study. Receiver operating characteristic (ROC) curve analysis identified a diaphragmatic thickening fraction (DTF) threshold of ≤25% for predicting ICU mortality (area under the curve [AUC] 0.87, sensitivity 85.1%, specificity 71.9%). Based on this cutoff, diaphragmatic dysfunction (DD) was present in 50.6% of patients on ICU admission and was associated with higher mortality (65.0% vs. 15.4%, p<0.001), fewer ICU-free days, and higher intubation rates. Survivors had significantly higher DTF values than non-survivors (30.7% vs. 18.8%, p<0.001). Multivariate analyses showed that DD on ICU admission was an independent predictor of mortality (HR 3.6, 95% CI 1.2-10.5, p=0.02), along with ferritin levels and the presence of septic shock.ConclusionsDD was common at ICU admission and was associated with higher intubation rates, fewer ICU-free days, and increased mortality. Early assessment of diaphragm function may help guide clinical management in non-intubated critically ill COVID-19 patients with acute respiratory failure, and a lower diaphragmatic thickening fraction may serve as a potential predictor of poor outcomes in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.